SPY311.36-0.82 -0.26%
DIA263.33+0.16 0.06%
IXIC9,615.81-67.10 -0.69%
News
VKTX
--
0.00%
--
Viking Therapeutics to Participate in Upcoming Investor Conferences
PR Newswire · 05/27 12:30
Edited Transcript of VKTX earnings conference call or presentation 30-Apr-20 8:30pm GMT
Thomson Reuters StreetEvents · 05/21 06:09
Viking Therapeutics Option Alert: Nov 20 $10 Calls Sweep (18) near the Ask: 563 @ $1.178 vs 274 OI; Ref=$7.4899
Benzinga · 05/20 17:17
7 Biotech Stocks Wall Street Says Will Double or More
Kiplinger · 05/19 21:08
Viking Therapeutics (VKTX) Investor Presentation - Slideshow
Seeking Alpha - Article · 05/19 19:09
Viking Therapeutics Announces 2020 Annual Meeting of Stockholders to be Held as Virtual Meeting
PR Newswire · 05/12 22:00
Genfit's elafibranor flunks NASH study; shares plummet 42% after hours
Based on an interim analysis, a Phase 3 clinical trial, RESOLVE-IT, evaluating Genfit's (NASDAQ:GNFT) elafibranor in adults with nonalcoholic steatohepatit
seekingalpha · 05/12 02:09
Why Viking Therapeutics Is Trading Higher Today
Viking Therapeutics Inc (NASDAQ: VKTX) shares are trading higher on Tuesday, after Chardan initiated coverage on the company's stock with a Buy rating and $15 price target.
Benzinga · 05/05 15:59
Benzinga's Top Upgrades, Downgrades For May 5, 2020
Upgrades
Benzinga · 05/05 13:35
Barclays issues flurry of healthcare ratings in premarket analyst action
Seeking Alpha - Article · 05/05 11:20
VKTX: Slight Delay in Enrollment in Phase 2b NASH Trial Due to Ongoing Pandemic
Zacks Small Cap Research · 05/05 11:00
Chardan Capital Initiates Coverage On Viking Therapeutics with Buy Rating, Announces Price Target to $15
Chardan Capital analyst Michael Morabito initiates coverage on Viking Therapeutics (NASDAQ:VKTX) with a Buy rating and announces Price Target to $15.
Benzinga · 05/05 10:20
3 Strong Buy Biotech Stocks Trading Under $10
TipRanks · 05/04 17:24
10 Biggest Price Target Changes For Monday
Morgan Stanley raised the price target on Charter Communications, Inc. (NASDAQ: CHTR) from $560 to $600. Charter Communications closed at $509.64 on Friday.
Benzinga · 05/04 12:17
B. Riley FBR Maintains Buy on Viking Therapeutics, Lowers Price Target to $12
B. Riley FBR maintains Viking Therapeutics (NASDAQ:VKTX) with a Buy and lowers the price target from $16 to $12.
Benzinga · 05/04 11:32
Benzinga's Top Upgrades, Downgrades For May 1, 2020
Upgrades
Benzinga · 05/01 13:40
Raymond James Maintains Strong Buy on Viking Therapeutics, Lowers Price Target to $25
Raymond James analyst Steven Seedhouse maintains Viking Therapeutics (NASDAQ:VKTX) with a Strong Buy and lowers the price target from $41 to $25.
Benzinga · 05/01 11:57
Guggenheim likes Seattle Genetics in premarket analyst action
Seeking Alpha - Article · 05/01 11:42
BTIG Initiates Coverage On Viking Therapeutics with Buy Rating, Announces Price Target to $9
BTIG initiates coverage on Viking Therapeutics (NASDAQ:VKTX) with a Buy rating and announces Price Target to $9.
Benzinga · 05/01 11:15
Viking Therapeutics, Inc. (VKTX) CEO Brian Lian on Q1 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 05/01 04:01